Velakast Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Velakast Tablet is a combination of two antiviral medicines, sofosbuvir and velpatasvir. Its labelling describes it for the treatment of chronic hepatitis C virus (HCV) infection, helping control the infection by fighting the virus. It is described as reducing the amount of hepatitis C virus in the body and removing it from the blood slowly over time to help the patient recover. It is a prescription medicine; the doctor decides the dose and how often it is used depending on the patient’s condition.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of chronic hepatitis C virus (HCV) infection
- Described as helping control the infection by fighting the virus
- Described as reducing the amount of hepatitis C virus in the body and clearing it from the blood over time
Described Dosage & Administration
- Used only when prescribed by the doctor
- The doctor decides the dose and how often it is used, depending on the patient’s condition
- The doctor’s advice should be strictly followed
Described Side Effects
Commonly described side effects include:
- Headache
- Tiredness
- Diarrhoea
Most of these are described as short-lived and as not requiring medical attention; a doctor should be consulted if they last longer.
Precautions
- Pregnant mothers should consult a doctor before use; described as possibly safe for breastfeeding mothers, though a doctor should be consulted first
- Described as unsafe to drive after taking the medicine
- Used with caution in patients with kidney problems
- Described as possibly safe for liver patients, to be used only if prescribed by the doctor
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it is a combination of sofosbuvir and velpatasvir used for the treatment of chronic hepatitis C virus infection. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as a prescription medicine taken as decided by the doctor, who sets the dose and frequency depending on the patient’s condition.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.